Infection with the hepatitis C virus (HCV) is now the most frequentcause of chronic hepatitis, cirrhosis, and hepatocellular carcinomain the United States and most Western nations.1,2,3 Population-basedsurveys show that 1 to 2 percent of adults in the United Statesare chronically infected with HCV.2 Although hepatitis C hasbeen described as an epidemic and a national emergency, theepidemic reflects the identification of chronic cases ratherthan a large outbreak of new cases.
Acute hepatitis C is no longer very common in the United States.The incidence has decreased from a peak level of 250,000 to500,000 . . . [Full Text of this Article]
References
This article has been cited by other articles:
Pimstone, N. R., Pimstone, D., Saicheur, T., Powell, J., Yu, A. S.
(2004). "Wait-and-See": An Alternative Approach to Managing Acute Hepatitis C with High-Dose Interferon-{alpha} Monotherapy. ANN INTERN MED
141: W-91-W-92
[Full Text]
Henderson, D. K.
(2003). Managing Occupational Risks for Hepatitis C Transmission in the Health Care Setting. Clin. Microbiol. Rev.
16: 546-568
[Abstract][Full Text]